Jim Cramer Just Discussed These 13 Stocks

11. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders In Q3 2024: 61

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a diversified pharmaceutical company with a presence in the generic, specialty, and other drug markets. Portfolio diversification enables the firm to fire on all fronts and simultaneously profit from high-volume generic medicines and higher prices specialty drugs. Consequently, during the first 11 months of the year, Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s shares gained 57% as the firm’s schizophrenia, migraine, and generic drug sales all jumped by either double or triple-digit percentages. For Cramer, the firm’s under-development drug for ulcerative colitis and Crohn’s disease is all the hype as he commented:

“Intractable disease [ULCERATIVE COLITIS AND CROHN’S] people have had some struggles with it, there are drugs out there that right now, they are so expensive, this would be a major break in inflation in the system. And they’re going right to three, and I thought it was very encouraging.”